|
1
|
Song YQ, Liu SP, Liu ZF and Hu XL:
Determination of matrine and oxymatrine in Radix Sophorae
Flavescentis by resonance rayleigh scattering, second-order
scattering and frequency doubling scattering technique. Chem Res
Chin Univ. 27:746–749. 2011.
|
|
2
|
Zhaowu Z, Xiaoli W, Yangde Z and Nianfeng
L: Preparation of matrine ethosome, its percutaneous permeation in
vitro and anti-inflammatory activity in vivo in rats. J Liposome
Res. 19:155–162. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Niu H, Zhang Y, Wu B, Zhang Y, Jiang H and
He P: Matrine induces the apoptosis of lung cancer cells through
downregulation of inhibitor of apoptosis proteins and the Akt
signaling pathway. Oncol Rep. 32:1087–1093. 2014.PubMed/NCBI
|
|
4
|
Liu YQ, Li Y, Qin J, Wang Q, She YL, Luo
YL, He JX, Li JY and Xie XD: Matrine reduces proliferation of human
lung cancer cells by inducing apoptosis and changing miRNA
expression profiles. Asian Pac J Cancer Prev. 15:2169–2177. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li H, Li X, Bai M, Suo Y, Zhang G and Cao
X: Matrine inhibited proliferation and increased apoptosis in human
breast cancer MCF-7 cells via upregulation of Bax and
downregulation of Bcl-2. Int J Clin Exp Pathol. 8:14793–14799.
2015.PubMed/NCBI
|
|
6
|
Gao H, Guo Y, Deng N, Fei P, Qiu X, Zheng
P, Feng J and Dai G: Suppressive effect of matrine on tumor
invasion in N-butyl-N-4-hydroxybutyl)nitrosamine-induced urinary
bladder carcinogenesis. Chemotherapy. 60:119–128. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li Q, Lai Y, Wang C, Xu G, He Z, Shang X,
Sun Y, Zhang F, Liu L and Huang H: Matrine inhibits the
proliferation, invasion and migration of castration-resistant
prostate cancer cells through regulation of the NF-κB signaling
pathway. Oncol Rep. 35:375–381. 2016.PubMed/NCBI
|
|
8
|
Rong B, Zhao C, Gao W and Yang S: Matrine
promotes the efficacy and safety of platinum-based doublet
chemotherapy for advanced non-small cell lung cancer. Int J Clin
Exp Med. 8:14701–14717. 2015.PubMed/NCBI
|
|
9
|
Wang HQ, Jin JJ and Wang J: Matrine
induces mitochondrial apoptosis in cisplatin-resistant non-small
cell lung cancer cells via suppression of β-catenin/survivin
signaling. Oncol Rep. 33:2561–2566. 2015.PubMed/NCBI
|
|
10
|
Flanagan L, Sebastià J, Tuffy LP, Spring
A, Lichawska A, Devocelle M, Prehn JH and Rehm M: XIAP impairs Smac
release from the mitochondria during apoptosis. Cell Death Dis.
1:e492010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kempkensteffen C, Jäger T, Bub J, Weikert
S, Hinz S, Christoph F, Krause H, Schostak M, Miller K and Schrader
M: The equilibrium of XIAP and Smac/DIABLO expression is gradually
deranged during the development and progression of testicular germ
cell tumours. Int J Androl. 30:476–483. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ramp U, Krieg T, Caliskan E, Mahotka C,
Ebert T, Willers R, Gabbert HE and Gerharz CD: XIAP expression is
an independent prognostic marker in clear-cell renal carcinomas.
Hum Pathol. 35:1022–1028. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hanson AJ, Wallace HA, Freeman TJ,
Beauchamp RD, Lee LA and Lee E: XIAP monoubiquitylates Groucho/TLE
to promote canonical Wnt signaling. Mol Cell. 45:619–628. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zheng ZL, Tan LZ, Yu YP, Michalopoulos G
and Luo JH: Interaction of CSR1 with XIAP reverses inhibition of
caspases and accelerates cell death. Am J Pathol. 181:463–471.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Berezovskaya O, Schimmer AD, Glinskii AB,
Pinilla C, Hoffman RM, Reed JC and Glinsky GV: Increased expression
of apoptosis inhibitor protein XIAP contributes to anoikis
resistance of circulating human prostate cancer metastasis
precursor cells. Cancer Res. 65:2378–2386. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Doudican NA, Byron SA, Pollock PM and
Orlow SJ: XIAP downregulation accompanies mebendazole growth
inhibition in melanoma xenografts. Anticancer Drugs. 24:181–188.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Castells M, Milhas D, Gandy C, Thibault B,
Rafii A, Delord JP and Couderc B: Microenvironment mesenchymal
cells protect ovarian cancer cell lines from apoptosis by
inhibiting XIAP inactivation. Cell Death Dis. 4:e8872013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cao Z, Li X, Li J, Luo W, Huang C and Chen
J: X-linked inhibitor of apoptosis protein (XIAP) lacking RING
domain localizes to the nuclear and promotes cancer cell
anchorage-independent growth by targeting the E2F1/Cyclin E axis.
Oncotarget. 5:7126–7137. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liew JC, Tan WS, Alitheen NB, Chan ES and
Tey BT: Over-expression of the X-linked inhibitor of apoptosis
protein (XIAP) delays serum deprivation-induced apoptosis in CHO-K1
cells. J Biosci Bioeng. 110:338–344. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Katragadda L, Carter BZ and Borthakur G:
XIAP antisense therapy with AEG 35156 in acute myeloid leukemia.
Expert Opin Investig Drugs. 22:663–670. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang CL, Liu SS, Ma YG, Liu YY, Xue YX and
Huang B: The influence of intraoperative pleural perfusion with
matrine- cisplatin or cisplatin on stromal cell-derived factor-1 in
non-small cell lung cancer patients with subclinical pleural
metastasis. Med Oncol. 29:574–581. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rossi S, Stoppani E, Puri PL and Fanzani
A: Differentiation of human rhabdomyosarcoma RD cells is regulated
by reciprocal, functional interactions between myostatin, p38 and
extracellular regulated kinase signalling pathways. Eur J Cancer.
47:1095–1105. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Paulino AC and Okcu MF: Rhabdomyosarcoma.
Curr Probl Cancer. 32:7–34. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Panta P and Felix D: Rhabdomyosarcoma: a
rapidly growing malignancy. Pan Afr Med J. 22:1212015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li H, Xie S, Liu X, Wu H, Lin X, Gu J,
Wang H and Duan Y: Matrine alters microRNA expression profiles in
SGC-7901 human gastric cancer cells. Oncol Rep. 32:2118–2126.
2014.PubMed/NCBI
|
|
26
|
Meng F, Zhang ZX, Xie J, Huang CB, Liu Y
and Liao YG: Effects of matrine on the apoptosis and the expression
of PEG10 in human hepatocarcinoma cell Line HepG2. J Pract Med.
10:1523–1526. 2014.(In Chinese).
|
|
27
|
Gao XH, Xu W, Li WJ, Ma HW and Bai YL:
Anti-proliferative effects of matrine on human neuroblastoma
SK-N-SH cells Chin. J Exp Trad Med Formulae. 23:196–199. 2013.(In
Chinese).
|
|
28
|
Yu Q, Chen B, Zhang X, Qian W, Ye B and
Zhou Y: Arsenic trioxide-enhanced, matrine-induced apoptosis in
multiple myeloma cell lines. Planta Med. 79:775–781. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yan F, Liu Y and Wang W: Matrine inhibited
the growth of rat osteosarcoma UMR-108 cells by inducing apoptosis
in a mitochondrial-caspase-dependent pathway. Tumour Biol.
34:2135–2140. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Guo L, Xue TY, Xu W and Gao JZ: Matrine
promotes G0/G1 arrest and down-regulates cyclin D1 expression in
human rhabdomyosarcoma cells. Panminerva Med. 55:291–296.
2013.PubMed/NCBI
|
|
31
|
Tan C, Qian X, Jia R, Wu M and Liang Z:
Matrine induction of reactive oxygen species activates p38 leading
to caspase-dependent cell apoptosis in non-small cell lung cancer
cells. Oncol Rep. 30:2529–2535. 2013.PubMed/NCBI
|
|
32
|
Liu Y, Xu Y, Ji W, Li X, Sun B, Gao Q and
Su C: Anti-tumor activities of matrine and oxymatrine: literature
review. Tumour Biol. 35:5111–5119. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guo L, Xue TY, Xu W and Gao JZ: Effects of
matrine on the proliferation and apoptosis of human
rhabdomyosarcoma RD cells. Zhongguo Dang Dai Er Ke Za Zhi.
14:780–784. 2012.(In Chinese). PubMed/NCBI
|
|
34
|
Li YX: Effects and mechanisms of matrine
on proliferation and apoptosis of human rhabdomyosarcoma cell RD.
Seek Med Ask Med:. 10:295–296. 2012.
|
|
35
|
Miao L, Guo S, Zhang J, Kim WY and Huang
L: Nanoparticles with precise ratiometric co-loading and
co-delivery of gemcitabine monophosphate and cisplatin for
treatment of bladder cancer. Adv Funct Mater. 24:6601–6611. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sárosi V and Lénárt T:
Gemcitabine-cisplatin combination in the first line treatment of
non-small cell lung cancer. Our experience and analysis of safety.
Magy Onkol. 47:189–193. 2003.(In Hungarian). PubMed/NCBI
|
|
37
|
Solár P, Horváth V, Kleban J, Koval' J,
Solárová Z, Kozubík A and Fedorocko P: Hsp90 inhibitor geldanamycin
increases the sensitivity of resistant ovarian adenocarcinoma cell
line A2780cis to cisplatin. Neoplasma. 54:127–130. 2007.PubMed/NCBI
|
|
38
|
Huang Q, Lu G, Shen HM, Chung MC and Ong
CN: Anti-cancer properties of anthraquinones from rhubarb. Med Res
Rev. 27:609–630. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yin PH, Liu X, Qiu YY, Cai JF, Qin JM, Zhu
HR and Li Q: Anti-tumor activity and apoptosis-regulation
mechanisms of bufalin in various cancers: new hope for cancer
patients. Asian Pac J Cancer Prev. 13:5339–5343. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tang MX: Reduction of metastasis of lung
cancer by ‘Fufang Shengmai-compound pulse inducer’ - a preliminary
report on experimental, clinical and pathologic study with
reference to the ultrastructure. Zhonghua Zhong Liu Za Zhi.
5:176–179. 1983.(In Chinese). PubMed/NCBI
|
|
41
|
Xiao WL, Motley TJ, Unachukwu UJ, Lau CB,
Jiang B, Hong F, Leung PC, Wang QF, Livingston PO, Cassileth BR, et
al: Chemical and genetic assessment of variability in commercial
Radix Astragali (Astragalus spp.) by ion trap LC-MS and nuclear
ribosomal DNA barcoding sequence analyses. J Agric Food Chem.
59:1548–1556. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Amantana A, London CA, Iversen PL and Devi
GR: X-linked inhibitor of apoptosis protein inhibition induces
apoptosis and enhances chemotherapy sensitivity in human prostate
cancer cells. Mol Cancer Ther. 3:699–707. 2004.PubMed/NCBI
|
